ASCO22: Chris Manz, MD on AI in oncology

ASCO22: Chris Manz, MD on AI in oncology

Artificial intelligence as a tool to increase discussions between patients and their oncology team about care goals can improve end-of-life care, according to research at led by Dana-Farber's Chris Manz, MD and presented at #ASCO22.


Created by


Related Presenters

Christopher Manz, MD, MSHP

Christopher Manz, MD, MSHP

Medical Oncology

Dr. Manz graduated from Duke University School of Medicine in 2012. He received his training in internal medicine at the Hospital of the University of Pennsylvania from 2012-2015, and subsequently worked as a hospitalist in oncology at ...

View Full Profile